This page is part of the FHIR Specification (v5.0.0-snapshot1: Release 5 Snapshot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
. Page versions: R5 R4B
| Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Basic Example of a drug authorization for Equilidem
{
"resourceType": "RegulatedAuthorization",
"id": "basic-drug-auth",
"text": {
"status": "generated",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div><p>Resource "basic-drug-auth" </p></div><p><b>subject</b>: <a>MedicinalProductDefinition/equilidem</a></p><p><b>type</b>: Regulatory Drug Marketing Approval <span> ()</span></p><p><b>status</b>: active <span> ([not stated]#active)</span></p><p><b>statusDate</b>: 2016-01-01</p><p><b>holder</b>: <a>Organization/EqlidrugCo: EquiliDrugCo Holdings Inc.</a></p><p><b>regulator</b>: <a>Organization/FDA: FDA</a></p></div>"
},
"subject": [
{
"reference": "MedicinalProductDefinition/equilidem"
}
],
"type": {
"text": "Regulatory Drug Marketing Approval"
},
"status": {
"coding": [
{
"code": "active"
}
]
},
"statusDate": "2016-01-01",
"holder": {
"reference": "Organization/EqlidrugCo",
"display": "EquiliDrugCo Holdings Inc."
},
"regulator": {
"reference": "Organization/FDA",
"display": "FDA"
}
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.